Tags: Drug.
67-Methylenedioxy-2-aminotetralin (MDAT) is a drug developed in the 1990s by a team at Purdue University led by David E. Nichols. It appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA in which it fully substitutes for and additionally lacks any kind of serotonergic neurotoxicity. Hence MDAT is considered likely to be a non-neurotoxic putative entactogen in humans.
